Purchases and Sales Made in Q4 2019 in Synthetic Biologics, Inc. (SYN)
This table provides information about the institutional ownership of Synthetic Biologics, Inc. (SYN) during Q4 2019. The information is specifically focused on institutions that hold shares of Synthetic Biologics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2020
Q4 2019
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
80.2K+ 15.99% |
$313K - $425K
|
582K
$349K
|
|
|
Jan 16, 2020
Q4 2019
|
Wedbush Securities Inc
|
BUY
|
- |
25K+ 23.45% |
$97.5K - $133K
|
132K
$79K
|
|
|
Feb 14, 2020
Q4 2019
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
4.27KNew |
$16.6K - $22.6K
|
4.27K
$2.56K
|
|
|
Feb 04, 2020
Q4 2019
|
Victory Capital Management Inc
|
BUY
|
- |
43+ 1.51% |
$168 - $228
|
2.89K
$1.73K
|
|
|
Feb 14, 2020
Q4 2019
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2020
Q4 2019
|
Blair William & CO
Chicago, IL |
SELL
|
- |
-1.69K- 3.19% |
$6.59K - $8.96K
|
51.3K
$30.8K
|
|
|
Feb 14, 2020
Q4 2019
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-25KClosed |
$97.4K - $132K
|
0
$0
|
|
|
Feb 14, 2020
Q4 2019
|
Ubs Group Ag
|
SELL
|
- |
-27.1K- 98.64% |
$106K - $143K
|
372
$223
|
|
|
Feb 14, 2020
Q4 2019
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-42.9KClosed |
$167K - $227K
|
0
$0
|
|
|
Feb 14, 2020
Q4 2019
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-148K- 17.73% |
$578K - $785K
|
687K
$412K
|